Brought to you by 
Oncology start-up Inception 2 spins off from Inception Sciences
25 Nov 2013
Executive Summary
Newly created drug discovery incubator Inception Sciences Inc. has spun off a second company, oncology-focused Inception 2 Inc., which has also received $5mm in financing from Versant Ventures and an unknown backer.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Spin-Off
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Oncology start-up Inception 2 spins off from Inception Sciences
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice